Novartis India Ltd
Ticker: NOVARTIND
Decent
72/100
☆ Add to Watchlist
Investing Reference
Price
868.05
Market Cap
2143.28
Debt/Equity
0.0064
ROE %
13.191
PB
2.7304
Promoter %
70.677
Pledge %
0.000
1Y Rev Growth %
0.824
5Y Rev Growth %
-5.352
NP Margin %
23.354
NP Margin 5Y Avg %
13.745
Trading Reference
1M Return %
-1.434
6M Return %
9.602
1Y Return %
-18.669
% Away 52W High
27.988
% Away 52W Low
16.525
Daily Volume
9484
Investment Verdict
Hold
Score 70/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 24/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
More Options
G
Goodyear India Ltd
Goodyear India Ltd shows a decent overall performance but faces challenges in profitability and growth drivers.
View details
S
Sasken Technologies Ltd
Sasken Technologies Ltd shows potential but faces several challenges that could impact future performance.
View details
G
GHV Infra Projects Ltd
GHV Infra Projects Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
M
Mayur Uniquoters Ltd
Mayur Uniquoters Ltd shows potential for growth with a decent financial standing, but investors should be cautious of valuation and execution risks.
View details
T
TIL Ltd
TIL Ltd shows potential in a growing sector but faces significant risks in execution and market sentiment, making it a risky investment at this time.
View details
I
Insecticides (India) Ltd
Insecticides (India) Ltd shows potential with decent growth prospects, but faces challenges in profitability and valuation metrics.
View details
I
ideaForge Technology Ltd
ideaForge Technology Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Investors should be cautious.
View details
S
Spectrum Electrical Industries Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
H
Hindustan Oil Exploration Company Ltd
Hindustan Oil Exploration Company Ltd shows potential in a transitioning sector but faces challenges in growth consistency and profitability metrics. Caution is advised due to execution risks and valuation concerns.
View details
S
Stove Kraft Ltd
Stove Kraft Ltd shows potential for growth in a competitive sector, but faces challenges in profitability and valuation metrics.
View details
T
TVS Srichakra Ltd
TVS Srichakra Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Investors should be cautious.
View details
G
GRM Overseas Ltd
GRM Overseas Ltd shows potential but faces challenges in growth consistency and market sentiment.
View details
D
Delta Corp Ltd
Delta Corp Ltd shows potential in a growing sector, but faces challenges in execution and valuation.
View details
J
John Cockerill India Ltd
While John Cockerill India Ltd operates in a promising sector, its financial performance and governance practices raise concerns. Investors should proceed with caution.
View details
A
Amrutanjan Health Care Ltd
Amrutanjan Health Care Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
Y
Yasho Industries Ltd
Yasho Industries Ltd shows decent potential with consistent growth and a solid business model, but some risks and governance issues need to be monitored.
View details
Business Overview
Novartis India Ltd is a leading pharmaceutical company dedicated to improving patient health through innovative medicines and therapies. Catering to a diverse population, it plays a crucial role in enhancing healthcare access across India. With a strong commitment to research and development, Novartis focuses on addressing unmet medical needs, making significant contributions to chronic and infectious disease management. The company's robust portfolio and strategic partnerships ensure a continuous supply of high-quality healthcare solutions.
- Established leader in the Indian pharmaceutical sector
- Focus on innovative and accessible healthcare solutions
- Strong commitment to research and development
- Wide-ranging portfolio addressing critical health issues
- Strategic partnerships enhancing market reach
Investment Thesis
Novartis India Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to its peers. These factors position the company well for sustained growth in the evolving pharmaceutical landscape.
- Strong backing from the global Novartis group enhances credibility and operational support.
- Robust growth trajectory in digital healthcare services offers a lucrative revenue stream.
- Attractive valuation metrics compared to industry peers suggest potential for price appreciation.
- Commitment to R&D ensures a pipeline of innovative products, driving future growth.
- Established market presence in India positions the company to capitalize on increasing healthcare demand.
Opportunity vs Risk
Opportunities
- Strong pipeline of new drugs
- Expanding presence in emerging markets
- Robust financial performance
- Focus on digital health solutions
- Potential for dividend growth
Risks ⚠️
- Regulatory challenges in India
- Intense competition in pharmaceuticals
- Currency fluctuations impact profits
- Patent expirations on key drugs
- Market volatility affecting stock price
Peer Perspective
Novartis India Ltd trades at a premium compared to peers like Sun Pharmaceutical and Dr. Reddy's Laboratories, reflecting its strong growth potential. A sustained improvement in margin stability could trigger a rerating in its valuation.
Future Outlook
Novartis India Ltd is well-positioned for future growth, driven by innovative product pipelines and expanding market presence, provided the company maintains strong execution and effective cost control measures.
AI FAQs for Retail Users
- Q: What does Novartis India Ltd do?A: Novartis India Ltd is a healthcare company focused on pharmaceuticals and generics.
- Q: Is Novartis India Ltd a good investment?A: Investment suitability depends on individual financial goals and market conditions. Do your research.
- Q: What are the risks of investing in Novartis India Ltd?A: Risks include market volatility, regulatory changes, and competition in the pharmaceutical sector.
- Q: How can I buy shares of Novartis India Ltd?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: What is the dividend policy of Novartis India Ltd?A: Dividends are declared based on company performance and board decisions; check recent announcements for updates.
📊 Stock Investment Checklist (100 Points)
Novartis India Ltd • Updated: 2025-09-17 05:54:37
-
10BusinessHighPharmaceutical sector is future-ready with strong demand.
-
10GrowthHighConsistent revenue growth over the past few years.
-
10ProfitabilityHighStrong ROE and OCF, but net profit margins are moderate.
-
8ValuationHighP/E ratio is higher than industry average.
-
7BalanceHighLow debt levels, good liquidity position.
-
9GovernanceHighStrong promoter holding with no pledging.
-
6DriversGoodGrowth drivers include new product launches, but execution risks exist.
-
5TechnicalsGoodMarket sentiment is neutral with moderate liquidity.
Final Score & Verdict
Score 72 / 100
• Decent
Novartis India Ltd shows decent potential with a strong business model and consistent growth, but valuation concerns and execution risks should be monitored.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 80/100
- Governance: 85/100
- Market Confidence: 78/100